The nationwide experiment will initially include around 100,000 volunteers.
A new vaccine that uses a persistent virus vector controlled SIV in 50 percent of tested monkeys
The Scientist
Most Recent
Columbia University evolutionary ecologist Dustin Rubenstein explains just why it's so interesting and important to find slime molds that engage in a form of agriculture.
Does mitochondrial dysfunction lie at the heart of common, complex diseases like cancer and autism?
Clostridium difficile is evolving more robust toxicity, repeatedly attacking its victims, and driving the search for alternative therapies to fight the infection.
A promising gene therapy trial, derailed by cancerous side effects in a young patient, is set to reboot with the help of next generation gene-transfer vectors.
Are miRNAs useful for tracking and treating cardiovascular disease?
Understanding oncogenesis at the molecular level offers the prospect of tailoring treatments much more precisely for patients with advanced cases of this deadliest of skin cancers.
Seventeenth-century Tibet witnessed a blossoming of medical knowledge, including a set of 79 paintings, known as tangkas, that interweaved practical medical knowledge with Buddhist traditions and local lore.
Popular Now
-
The Nutshell Estonia Offers Free Genetic Testing to Residents -
Daily News Human Brain Organoids Thrive in Mouse Brains After implantation, the tissue developed blood vessels and became integrated into neuronal networks in the animals’ brains.
-
The Nutshell New Ovarian Cancer Vaccine Shows Promise A preliminary clinical trial finds that the personalized therapy improves survival rates and has no severe side-effects.
-
Daily News The Second March for Science a Smaller Affair Many cities around the globe, including Washington, DC, saw shrunken crowd sizes, and numerous events turned into rallies rather than processions.
Current Issue
© 1986-2018 The Scientist
